Insights into mechanisms behind arteriogenesis: What does the future hold?

Journal of Leukocyte Biology

Volumn 84, Issue 6, 2008, Pages 1379-1391

  Van Oostrom, Melany C ^a   Van Oostrom, Olivia ^a   Quax, Paul H A ^b,c   Verhaar, Marianne C ^a   Hoefer, Imo E ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b TNO   (Netherlands)

^c LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Cell therapy; Growth factors

Indexed keywords

GROWTH FACTOR; MONOCYTE CHEMOTACTIC PROTEIN 1; VASCULOTROPIN; VASCULOTROPIN A; VASCULOTROPIN B; VASCULOTROPIN C; VASCULOTROPIN D;

ANGIOGENESIS; BLOOD FLOW; CELL DIFFERENTIATION; CELL THERAPY; CELL TYPE; CLINICAL TRIAL; HUMAN; NEOVASCULARIZATION (PATHOLOGY); PRIORITY JOURNAL; REVIEW;

ANGIOGENESIS INDUCING AGENTS; ARTERIAL OCCLUSIVE DISEASES; COLLATERAL CIRCULATION; HUMANS; NEOVASCULARIZATION, PHYSIOLOGIC;

EID: 57149092425     PISSN: 07415400     EISSN: None     Source Type: Journal    
DOI: 10.1189/jlb.0508281     Document Type: Review

References (138)

1. World Health Organization (February 2007) Factsheet 317.
2. Helfant, R. H., Vokonas, P. S., Gorlin, R. (1971) Functional importance of the human coronary collateral circulation. N. Engl. J. Med. 284, 1277-1281.
3. Prior, B. M., Yang, H. T., Terjung, R. L. (2004) What makes vessels grow with exercise training? J. Appl. Physiol. 97, 1119-1128.
4. Carmeliet, P. (2000) Mechanisms of angiogenesis and arteriogenesis. Nat. Med. 6, 389-395.
5. Konkle, B. A., Schafer, A. I. (2005) Hemostasis, thrombosis, fibrinolysis, and cardiovascular disease. Braunwald's Heart Disease 7th edition (D. P. Zipes and E. Braunwald, eds.), Philadelphia, PA, USA, Saunders.
6. Takahashi, T., Kalka, C., Masuda, H., Chen, D., Silver, M., Kearney, M., Magner, M., Isner, J. M., Asahara, T. (1999) Ischemia- and cytokineinduced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization. Nat. Med. 5, 434-438.
7. Asahara, T., Murohara, T., Sullivan, A., Silver, M., van der Zee, R., Li, T., Witzenbichler, B., Schatteman, G., Isner, J. M. (1997) Isolation of putative progenitor endothelial cells for angiogenesis. Science 275, 964-967.
8. Scholz, D., Ziegelhoeffer, T., Helisch, A., Wagner, S., Friedrich, C., Podzuweit, T., Schaper, W. (2002) Contribution of arteriogenesis and angiogenesis to postocclusive hindlimb perfusion in mice. J. Mol. Cell. Cardiol. 34, 775-787.
9. Heil, M., Schaper, W. (2004) Influence of mechanical, cellular, and molecular factors on collateral artery growth (arteriogenesis). Circ. Res. 95, 449-458.
10. Ito, W. D., Arras, M., Scholz, D., Winkler, B., Htun, P., Schaper, W. (1997) Angiogenesis but not collateral growth is associated with ischemia after femoral artery occlusion. Am. J. Physiol. 273, H1255-H1265.
11. Schaper, W., Scholz, D. (2003) Factors regulating arteriogenesis. Arterioscler. Thromb. Vasc. Biol. 23, 1143-1151.
12. Deindl, E., Buschmann, I., Hoefer, I. E., Podzuweit, T., Boengler, K., Vogel, S., van Royen, N., Fernandez, B., Schaper, W. (2001) Role of ischemia and of hypoxia-inducible genes in arteriogenesis after femoral artery occlusion in the rabbit. Circ. Res. 89, 779-786.
13. Ito, W. D., Arras, M., Winkler, B., Scholz, D., Schaper, J., Schaper, W. (1997) Monocyte chemotactic protein-1 increases collateral and peripheral conductance after femoral artery occlusion. Circ. Res. 80, 829-837.
14. Pipp, F., Boehm, S., Cai, W. J., Adili, F., Ziegler, B., Karanovic, G., Ritter, R., Balzer, J., Scheler, C., Schaper, W., Schmitz-Rixen, T. (2004) Elevated fluid shear stress enhances postocclusive collateral artery growth and gene expression in the pig hind limb. Arterioscler. Thromb. Vasc. Biol. 24, 1664-1668.
15. Wolf, C., Cai, W. J., Vosschulte, R., Koltai, S., Mousavipour, D., Scholz, D., Afsah-Hedjri, A., Schaper, W., Schaper, J. (1998) Vascular remodeling and altered protein expression during growth of coronary collateral arteries. J. Mol. Cell. Cardiol. 30, 2291-2305.
16. Heil, M., Eitenmuller, I., Schmitz-Rixen, T., Schaper, W. (2006) Arteriogenesis versus angiogenesis: similarities and differences. J. Cell. Mol. Med. 10, 45-55.
17. Hoefer, I. E., Piek, J. J., Pasterkamp, G. (2006) Pharmaceutical interventions to influence arteriogenesis: new concepts to treat ischemic heart disease. Curr. Med. Chem. 13, 979-987.
18. Davies, P. F. (1995) Flow-mediated endothelial mechanotransduction. Physiol. Rev. 75, 519-560.
19. Jalali, S., del Pozo, M. A., Chen, K., Miao, H., Li, Y., Schwartz, M. A., Shyy, J. Y., Chien, S. (2001) Integrin-mediated mechanotransduction requires its dynamic interaction with specific extracellular matrix (ECM) ligands. Proc. Natl. Acad. Sci. USA 98, 1042-1046.
20. Chen, K. D., Li, Y. S., Kim, M., Li, S., Yuan, S., Chien, S., Shyy, J. Y. (1999) Mechanotransduction in response to shear stress. Roles of receptor tyrosine kinases, integrins, and Shc. J. Biol. Chem. 274, 18393-18400.
21. Jin, Z. G., Ueba, H., Tanimoto, T., Lungu, A. O., Frame, M. D., Berk, B. C. (2003) Ligand-independent activation of vascular endothelial growth factor receptor 2 by fluid shear stress regulates activation of endothelial nitric oxide synthase. Circ. Res. 93, 354-363.
22. Chachisvilis, M., Zhang, Y. L., Frangos, J. A. (2006) G protein-coupled receptors sense fluid shear stress in endothelial cells. Proc. Natl. Acad. Sci. USA 103, 15463-15468.
23. Davies, P. F., Barbee, K. A., Volin, M. V., Robotewskyj, A., Chen, J., Joseph, L., Griem, M. L., Wernick, M. N., Jacobs, E., Polacek, D. C., dePaola, N., Barakat, A. I. (1997) Spatial relationships in early signaling events of flow-mediated endothelial mechanotransduction. Annu. Rev. Physiol. 59, 527-549.
24. Nilius, B., Droogmans, G. (2001) Ion channels and their functional role in vascular endothelium. Physiol. Rev. 81, 1415-1459.
25. Hoefer, I. E., van Royen, N., Rectenwald, J. E., Deindl, E., Hua, J., Jost, M., Grundmann, S., Voskuil, M., Ozaki, C. K., Piek, J. J., Buschmann, I. R. (2004) Arteriogenesis proceeds via ICAM-1/Mac-1- mediated mechanisms. Circ. Res. 94, 1179-1185.
26. Scholz, D., Ito, W., Fleming, I., Deindl, E., Sauer, A., Wiesnet, M., Busse, R., Schaper, J., Schaper, W. (2000) Ultrastructure and molecular histology of rabbit hind-limb collateral artery growth (arteriogenesis). Virchows Arch. 436, 257-270.
27. Hoefer, I. E., van Royen, N., Rectenwald, J. E., Bray, E. J., Abouhamze, Z., Moldawer, L. L., Voskuil, M., Piek, J. J., Buschmann, I. R., Ozaki, C. K. (2002) Direct evidence for tumor necrosis factor-α signaling in arteriogenesis. Circulation 105, 1639-1641.
28. Luo, D., Luo, Y., He, Y., Zhang, H., Zhang, R., Li, X., Dobrucki, W. L., Sinusas, A. J., Sessa, W. C., Min, W. (2006) Differential functions of tumor necrosis factor receptor 1 and 2 signaling in ischemia-mediated arteriogenesis and angiogenesis. Am. J. Pathol. 169, 1886-1898.
29. Kosaki, K., Ando, J., Korenaga, R., Kurokawa, T., Kamiya, A. (1998) Fluid shear stress increases the production of granulocyte-macrophage colony-stimulating factor by endothelial cells via mRNA stabilization. Circ. Res. 82, 794-802.
30. Cai, W. J., Kocsis, E., Luo, X., Schaper, W., Schaper, J. (2004) Expression of endothelial nitric oxide synthase in the vascular wall during arteriogenesis. Mol. Cell. Biochem. 264, 193-200.
31. Heil, M., Ziegelhoeffer, T., Wagner, S., Fernandez, B., Helisch, A., Martin, S., Tribulova, S., Kuziel, W. A., Bachmann, G., Schaper, W. (2004) Collateral artery growth (arteriogenesis) after experimental arterial occlusion is impaired in mice lacking CC-chemokine receptor-2. Circ. Res. 94, 671-677.
32. Schaper, J., Konig, R., Franz, D., Schaper, W. (1976) The endothelial surface of growing coronary collateral arteries. Intimal margination and diapedesis of monocytes. A combined SEM and TEM study. Virchows Arch. A Pathol. Anat. Histol. 370, 193-205.
33. Arras, M., Ito, W. D., Scholz, D., Winkler, B., Schaper, J., Schaper, W. (1998) Monocyte activation in angiogenesis and collateral growth in the rabbit hindlimb. J. Clin. Invest. 101, 40-50.
34. Grundmann, S., Hoefer, I., Ulusans, S., Bode, C., Oesterle, S., Tijssen, J. G., Piek, J. J., Buschmann, I., van Royen, N. (2006) Granulocytemacrophage colony-stimulating factor stimulates arteriogenesis in a pig model of peripheral artery disease using clinically applicable infusion pumps. J. Vasc. Surg. 43, 1263-1269.
35. Bergmann, C. E., Hoefer, I. E., Meder, B., Roth, H., van Royen, N., Breit, S. M., Jost, M. M., Aharinejad, S., Hartmann, S., Buschmann, I. R. (2006) Arteriogenesis depends on circulating monocytes and macrophage accumulation and is severely depressed in op/op mice. J. Leukoc. Biol. 80, 59-65.
36. Couffinhal, T., Silver, M., Kearney, M., Sullivan, A., Witzenbichler, B., Magner, M., Annex, B., Peters, K., Isner, J. M. (1999) Impaired collateral vessel development associated with reduced expression of vascular endothelial growth factor in ApoE-/- mice. Circulation 99, 3188-3198.
37. Stabile, E., Burnett, M. S., Watkins, C., Kinnaird, T., Bachis, A., la Sala, A., Miller, J. M., Shou, M., Epstein, S. E., Fuchs, S. (2003) Impaired arteriogenic response to acute hindlimb ischemia in CD4- knockout mice. Circulation 108, 205-210.
38. Van Weel, V., Toes, R. E., Seghers, L., Deckers, M. M., de Vries, M. R., Eilers, P. H., Sipkens, J., Schepers, A., Eefting, D., van Hinsbergh, V. W., van Bockel, J. H., Quax, P. H. (2007) Natural killer cells and CD4+ T-cells modulate collateral artery development. Arterioscler. Thromb. Vasc. Biol. 27, 2310-2318.
39. Welgus, H. G., Campbell, E. J., Cury, J. D., Eisen, A. Z., Senior, R. M., Wilhelm, S. M., Goldberg, G. I. (1990) Neutral metalloproteinases produced by human mononuclear phagocytes. Enzyme profile, regulation, and expression during cellular development. J. Clin. Invest. 86, 1496-1502.
40. Polverini, P. J., Cotran, P. S., Gimbrone Jr., M. A., Unanue, E. R. (1977) Activated macrophages induce vascular proliferation. Nature 269, 804-806.
41. Cai, W., Vosschulte, R., Afsah-Hedjri, A., Koltai, S., Kocsis, E., Scholz, D., Kostin, S., Schaper, W., Schaper, J. (2000) Altered balance between extracellular proteolysis and antiproteolysis is associated with adaptive coronary arteriogenesis. J. Mol. Cell. Cardiol. 32, 997-1011.
42. Lindahl, P., Johansson, B. R., Leveen, P., Betsholtz, C. (1997) Pericyte loss and microaneurysm formation in PDGF-B-deficient mice. Science 277, 242-245.
43. Hellstrom, M., Kalen, M., Lindahl, P., Abramsson, A., Betsholtz, C. (1999) Role of PDGF-B and PDGFR-β in recruitment of vascular smooth muscle cells and pericytes during embryonic blood vessel formation in the mouse. Development 126, 3047-3055.
44. Buschmann, I., Schaper, W. (1999) Arteriogenesis versus angiogenesis: two mechanisms of vessel growth. News Physiol. Sci. 14, 121-125.
45. Sata, M. (2006) Role of circulating vascular progenitors in angiogenesis, vascular healing, and pulmonary hypertension: lessons from animal models. Arterioscler. Thromb. Vasc. Biol. 26, 1008-1014.
46. Song, S., Ewald, A. J., Stallcup, W., Werb, Z., Bergers, G. (2005) PDGFRβ+ perivascular progenitor cells in tumors regulate pericyte differentiation and vascular survival. Nat. Cell Biol. 7, 870-879.
47. Ziegelhoeffer, T., Fernandez, B., Kostin, S., Heil, M., Voswinckel, R., Helisch, A., Schaper, W. (2004) Bone marrow-derived cells do not incorporate into the adult growing vasculature. Circ. Res. 94, 230-238.
48. Kinnaird, T., Stabile, E., Burnett, M. S., Lee, C. W., Barr, S., Fuchs, S., Epstein, S. E. (2004) Marrow-derived stromal cells express genes encoding a broad spectrum of arteriogenic cytokines and promote in vitro and in vivo arteriogenesis through paracrine mechanisms. Circ. Res. 94, 678-685.
49. Zbinden, R., Billinger, M., Seiler, C. (2004) Collateral vessel physiology and functional impact-experimental evidence of collateral behavior. Coron. Artery Dis. 15, 389-392.
50. Pohl, T., Seiler, C., Billinger, M., Herren, E., Wustmann, K., Mehta, H., Windecker, S., Eberli, F. R., Meier, B. (2001) Frequency distribution of collateral flow and factors influencing collateral channel development. Functional collateral channel measurement in 450 patients with coronary artery disease. J. Am. Coll. Cardiol. 38, 1872-1878.
51. Fujita, M., Sasayama, S., Asanoi, H., Nakajima, H., Sakai, O., Ohno, A. (1988) Improvement of treadmill capacity and collateral circulation as a result of exercise with heparin pretreatment in patients with effort angina. Circulation 77, 1022-1029.
52. Kastrup, J., Jorgensen, E., Ruck, A., Tagil, K., Glogar, D., Ruzyllo, W., Botker, H. E., Dudek, D., Drvota, V., Hesse, B., Thuesen, L., Blomberg, P., Gyongyosi, M., Sylven, C. (2005) Direct intramyocardial plasmid vascular endothelial growth factor-A165 gene therapy in patients with stable severe angina pectoris A randomized double-blind placebo-controlled study: the Euroinject One trial. J. Am. Coll. Cardiol. 45, 982-988.
53. Hedman, M., Hartikainen, J., Syvanne, M., Stjernvall, J., Hedman, A., Kivela, A., Vanninen, E., Mussalo, H., Kauppila, E., Simula, S., Narvanen, O., Rantala, A., Peuhkurinen, K., Nieminen, M. S., Laakso, M., Yla-Herttuala, S. (2003) Safety and feasibility of catheter-based local intracoronary vascular endothelial growth factor gene transfer in the prevention of postangioplasty and in-stent restenosis and in the treatment of chronic myocardial ischemia: phase II results of the Kuopio Angiogenesis Trial (KAT). Circulation 107, 2677-2683.
54. Grines, C. L., Watkins, M. W., Helmer, G., Penny, W., Brinker, J., Marmur, J. D., West, A., Rade, J. J., Marrott, P., Hammond, H. K., Engler, R. L. (2002) Angiogenic Gene Therapy (AGENT) trial in patients with stable angina pectoris. Circulation 105, 1291-1297.
55. Simons, M., Annex, B. H., Laham, R. J., Kleiman, N., Henry, T., Dauerman, H., Udelson, J. E., Gervino, E. V., Pike, M., Whitehouse, M. J., Moon, T., Chronos, N. A. (2002) Pharmacological treatment of coronary artery disease with recombinant fibroblast growth factor-2: double-blind, randomized, controlled clinical trial. Circulation 105, 788-793.
56. Henry, T. D., Annex, B. H., McKendall, G. R., Azrin, M. A., Lopez, J. J., Giordano, F. J., Shah, P. K., Willerson, J. T., Benza, R. L., Berman, D. S., Gibson, C. M., Bajamonde, A., Rundle, A. C., Fine, J., McCluskey, E. R. (2003) The VIVA trial: Vascular Endothelial Growth Factor in Ischemia for Vascular Angiogenesis. Circulation 107, 1359-1365.
57. Stewart, D. J., Hilton, J. D., Arnold, J. M., Gregoire, J., Rivard, A., Archer, S. L., Charbonneau, F., Cohen, E., Curtis, M., Buller, C. E., Mendelsohn, F. O., Dib, N,. Page, P., Ducas, J., Plante, S., Sullivan, J., Macko, J., Rasmussen, C., Kessler, P. D., Rasmussen, H. S. (2006) Angiogenic gene therapy in patients with nonrevascularizable ischemic heart disease: a phase 2 randomized, controlled trial of AdVEGF(121) (AdVEGF121) versus maximum medical treatment. Gene Ther. 13, 1503-1511.
58. Zohlnhöfer, D., Ott, I., Mehilli, J., Schomig, K., Michalk, F., Ibrahim, T., Meisetschlager, G., von Wedel, J., Bollwein, H., Seyfarth, M., Dirschinger, J., Schmitt, C., Schwaiger, M., Kastrati, A., Schomig, A. (2006) Stem cell mobilization by granulocyte colony-stimulating factor in patients with acute myocardial infarction: a randomized controlled trial. JAMA 295, 1003-1010.
59. Seiler, C., Pohl, T., Wustmann, K., Hutter, D., Nicolet, P. A., Windecker, S., Eberli, F. R., Meier, B. (2001) Promotion of collateral growth by granulocyte-macrophage colony-stimulating factor in patients with coronary artery disease: a randomized, double-blind, placebo-controlled study. Circulation 104, 2012-2017.
60. Ripa, R. S., Jorgensen, E., Wang, Y., Thune, J. J., Nilsson, J. C., Sondergaard, L., Johnsen, H. E., Kober, L., Grande, P., Kastrup, J. (2006) Stem cell mobilization induced by subcutaneous granulocyte-colony stimulating factor to improve cardiac regeneration after acute ST-elevation myocardial infarction: result of the double-blind, randomized, placebo-controlled stem cells in myocardial infarction (STEMMI) trial. Circulation 113, 1983-1992.
61. Ince, H., Petzsch, M., Kleine, H. D., Eckard, H., Rehders, T., Burska, D., Kische, S., Freund, M., Nienaber, C. A. (2005) Prevention of left ventricular remodeling with granulocyte colony-stimulating factor after acute myocardial infarction: final 1-year results of the Front-Integrated Revascularization and Stem Cell Liberation in Evolving Acute Myocardial Infarction by Granulocyte Colony-Stimulating Factor (FIRSTLINE-AMI) Trial. Circulation 112, I73-I80.
62. Erbs, S., Linke, A., Schachinger, V., Assmus, B., Thiele, H., Diederich, K. W., Hoffmann, C., Dimmeler, S., Tonn, T., Hambrecht, R., Zeiher, A. M., Schuler, G. (2007) Restoration of microvascular function in the infarct-related artery by intracoronary transplantation of bone marrow progenitor cells in patients with acute myocardial infarction: the Doppler Substudy of the Reinfusion of Enriched Progenitor Cells and Infarct Remodeling in Acute Myocardial Infarction (REPAIR-AMI) trial. Circulation 116, 366-374.
63. Janssens, S., Dubois, C., Bogaert, J., Theunissen, K., Deroose, C., Desmet, W., Kalantzi, M., Herbots, L., Sinnaeve, P., Dens, J., Maertens, J., Rademakers, F., Dymarkowski, S., Gheysens, O., Van Cleemput, J., Bormans, G., Nuyts, J., Belmans, A., Mortelmans, L., Boogaerts, M., Van de Werf, F. (2006) Autologous bone marrow-derived stem-cell transfer in patients with ST-segment elevation myocardial infarction: double-blind, randomized controlled trial. Lancet 367, 113-121.
64. Meyer, G. P., Wollert, K. C., Lotz, J., Steffens, J., Lippolt, P., Fichtner, S., Hecker, H., Schaefer, A., Arseniev, L., Hertenstein, B., Ganser, A., Drexler, H. (2006) Intracoronary bone marrow cell transfer after myocardial infarction: eighteen months' follow-up data from the randomized, controlled BOOST (Bone Marrow Transfer to Enhance ST-Elevation Infarct Regeneration) trial. Circulation 113, 1287-1294.
65. Kang, H. J., Lee, H. Y., Na, S. H., Chang, S. A., Park, K. W., Kim, H. K., Kim, S. Y., Chang, H. J., Lee, W., Kang, W. J., Koo, B. K., Kim, Y. J., Lee, D. S., Sohn, D. W., Han, K. S., Oh, B. H., Park, Y. B., Kim, H. S. (2006) Differential effect of intracoronary infusion of mobilized peripheral blood stem cells by granulocyte colony-stimulating factor on left ventricular function and remodeling in patients with acute myocardial infarction versus old myocardial infarction: the MAGIC Cell-3-DES randomized, controlled trial. Circulation 114, I145-I151.
66. Schächinger, V., Erbs, S., Elsasser, A., Haberbosch, W., Hambrecht, R., Holschermann, H., Yu, J., Corti, R., Mathey, D. G., Hamm, C. W., Suselbeck, T., Assmus, B., Tonn, T., Dimmeler, S., Zeiher, A. M. (2006) Intracoronary bone marrow-derived progenitor cells in acute myocardial infarction. N. Engl. J. Med. 355, 1210-1221.
67. Nikol, S., Baumgartner, I., Van Belle, E., Diehm, C., Visona, A., Capogrossi, M. C., Ferreira-Maldent, N., Gallino, A., Wyatt, M. G., Wijesinghe, L. D., Fusari, M., Stephan, D., Emmerich, J., Pompilio, G., Vermassen, F., Pham, E., Grek, V., Coleman, M., Meyer, F. (2008) Therapeutic angiogenesis with intramuscular NV1FGF improves amputation-free survival in patients with critical limb ischemia. Mol. Ther. 16, 972-978.
68. Makinen, K., Manninen, H., Hedman, M., Matsi, P., Mussalo, H., Alhava, E., Yla-Herttuala, S. (2002) Increased vascularity detected by digital subtraction angiography after VEGF gene transfer to human lower limb artery: a randomized, placebo-controlled, double-blinded phase II study. Mol. Ther. 6, 127-133.
69. Rajagopalan, S., Mohler III, E. R., Lederman, R. J., Mendelsohn, F. O., Saucedo, J. F., Goldman, C. K., Blebea, J., Macko, J., Kessler, P. D., Rasmussen, H. S., Annex, B. H. (2003) Regional angiogenesis with vascular endothelial growth factor in peripheral arterial disease: a phase II randomized, double-blind, controlled study of adenoviral delivery of vascular endothelial growth factor 121 in patients with disabling intermittent claudication. Circulation 108, 1933-1938.
70. Lederman, R. J., Mendelsohn, F. O., Anderson, R. D., Saucedo, J. F., Tenaglia, A. N., Hermiller, J. B., Hillegass, W. B., Rocha-Singh, K., Moon, T. E., Whitehouse, M. J., Annex, B. H. (2002) Therapeutic angiogenesis with recombinant fibroblast growth factor-2 for intermittent claudication (the TRAFFIC study): a randomized trial. Lancet 359, 2053-2058.
71. Kusumanto, Y. H., van Weel, V., Mulder, N. H., Smit, A. J., van den Dungen, J. J., Hooymans, J. M., Sluiter, W. J., Tio, R. A., Quax, P. H., Gans, R. O., Dullaart, R. P., Hospers, G. A. (2006) Treatment with intramuscular vascular endothelial growth factor gene compared with placebo for patients with diabetes mellitus and critical limb ischemia: a double-blind randomized trial. Hum. Gene Ther. 17, 683-691.
72. Powell, R. J., Simons, M., Mendelsohn, F. O., Daniel, G., Henry, T. D., Koga, M., Morishita, R., Annex, B. H. (2008) Results of a double-blind, placebo-controlled study to assess the safety of intramuscular injection of hepatocyte growth factor plasmid to improve limb perfusion in patients with critical limb ischemia. Circulation 118, 58-65.
73. Van Royen, N., Schirmer, S. H., Atasever, B., Behrens, C. Y., Ubbink, D., Buschmann, E. E., Voskuil, M., Bot, P., Hoefer, I., Schlingemann, R. O., Biemond, B. J., Tijssen, J. G., Bode, C., Schaper, W., Oskam, J., Legemate, D. A., Piek, J. J., Buschmann, I. (2005) START Trial: a pilot study on STimulation of ARTeriogenesis using subcutaneous application of granulocyte-macrophage colony-stimulating factor as a new treatment for peripheral vascular disease. Circulation 112, 1040-1046.
74. Huang, P., Li, S., Han, M., Xiao, Z., Yang, R., Han, Z. C. (2005) Autologous transplantation of granulocyte colony-stimulating factor-mobilized peripheral blood mononuclear cells improves critical limb ischemia in diabetes. Diabetes Care 28, 2155-2160.
75. Tateishi-Yuyama, E., Matsubara, H., Murohara, T., Ikeda, U., Shintani, S., Masaki, H., Amano, K., Kishimoto, Y., Yoshimoto, K., Akashi, H., Shimada, K., Iwasaka, T., Imaizumi, T. (2002) Therapeutic angiogenesis for patients with limb ischemia by autologous transplantation of bonemarrow cells: a pilot study and a randomized controlled trial. Lancet 360, 427-435.
76. Leung, D. W., Cachianes, G., Kuang, W. J., Goeddel, D. V., Ferrara, N. (1989) Vascular endothelial growth factor is a secreted angiogenic mitogen. Science 246, 1306-1309.
77. Ferrara, N., Gerber, H. P., LeCouter, J. (2003) The biology of VEGF and its receptors. Nat. Med. 9, 669-676.
78. Clauss, M., Weich, H., Breier, G., Knies, U., Rockl, W., Waltenberger, J., Risau, W. (1996) The vascular endothelial growth factor receptor Flt-1 mediates biological activities. Implications for a functional role of placenta growth factor in monocyte activation and chemotaxis. J. Biol. Chem. 271, 17629-17634.
79. Laramee, M., Chabot, C., Cloutier, M., Stenne, R., Holgado-Madruga, M., Wong, A. J., Royal, I. (2007) The scaffolding adapter Gab1 mediates vascular endothelial growth factor signaling and is required for endothelial cell migration and capillary formation. J. Biol. Chem. 282, 7758-7769.
80. Rivard, A., Silver, M., Chen, D., Kearney, M., Magner, M., Annex, B., Peters, K., Isner, J. M. (1999) Rescue of diabetes-related impairment of angiogenesis by intramuscular gene therapy with adeno-VEGF. Am. J. Pathol. 154, 355-363.
81. Mack, C. A., Magovern, C. J., Budenbender, K. T., Patel, S. R., Schwarz, E. A., Zanzonico, P., Ferris, B., Sanborn, T., Isom, P., Ferris, B., Sanborn, T., Isom, O. W., Crystal, R. G., Rosengart, T. K. (1998) Salvage angiogenesis induced by adenovirus-mediated gene transfer of vascular endothelial growth factor protects against ischemic vascular occlusion. J. Vasc. Surg. 27, 699-709.
82. Leong-Poi, H., Kuliszewski, M. A., Lekas, M., Sibbald, M., Teichert-Kuliszewska, K., Klibanov, A. L., Stewart, D. J., Lindner, J. R. (2007) Therapeutic arteriogenesis by ultrasound-mediated VEGF165 plasmid gene delivery to chronically ischemic skeletal muscle. Circ. Res. 101, 295-303.
83. Greve, J. M., Chico, T. J., Goldman, H., Bunting, S., Peale Jr., F. V., Daugherty, A., van Bruggen, N., Williams, S. P. (2006) Magnetic resonance angiography reveals therapeutic enlargement of collateral vessels induced by VEGF in a murine model of peripheral arterial disease. J. Magn. Reson. Imaging 24, 1124-1132.
84. Von Degenfeld, G., Banfi, A., Springer, M. L., Wagner, R. A., Jacobi, J., Ozawa, C. R., Merchant, M. J., Cooke, J. P., Blau, H. M. (2006) Microenvironmental VEGF distribution is critical for stable and functional vessel growth in ischemia. FASEB J. 20, 2657-2659.
85. Baumgartner, I., Pieczek, A., Manor, O., Blair, R., Kearney, M., Walsh, K., Isner, J. M. (1998) Constitutive expression of phVEGF165 after intramuscular gene transfer promotes collateral vessel development in patients with critical limb ischemia. Circulation 97, 1114-1123.
86. Rissanen, T. T., Yla-Herttuala, S. (2007) Current status of cardiovascular gene therapy. Mol. Ther. 15, 1233-1247.
87. van Weel, V., Deckers, M. M., Grimbergen, J. M., van Leuven, K. J., Lardenoye, J. H., Schlingemann, R. O., van Nieuw Amerongen, G. P., van Bockel, J. H., van Hinsbergh, V. W., Quax, P. H. (2004) Vascular endothelial growth factor overexpression in ischemic skeletal muscle enhances myoglobin expression in vivo. Circ. Res. 95, 58-66.
88. Heil, M., Clauss, M., Suzuki, K., Buschmann, I. R., Willuweit, A., Fischer, S., Schaper, W. (2000) Vascular endothelial growth factor (VEGF) stimulates monocyte migration through endothelial monolayers via increased integrin expression. Eur. J. Cell Biol. 79, 850-857.
89. Simons, M. (2005) Angiogenesis: where do we stand now? Circulation 111, 1556-1566.
90. Masaki, I., Yonemitsu, Y., Yamashita, A., Sata, S., Tanii, M., Komori, K., Nakagawa, K., Hou, X., Nagai, Y., Hasegawa, M., Sugimachi, K., Sueishi, K. (2002) Angiogenic gene therapy for experimental critical limb ischemia: acceleration of limb loss by overexpression of vascular endothelial growth factor 165 but not of fibroblast growth factor-2. Circ. Res. 90, 966-973.
91. Pipp, F., Heil, M., Issbrucker, K., Ziegelhoeffer, T., Martin, S., van den Heuvel, J., Weich, H., Fernandez, B., Golomb, G., Carmeliet, P., Schaper, W., Clauss, M. (2003) VEGFR-1-selective VEGF homologue PlGF is arteriogenic: evidence for a monocyte-mediated mechanism. Circ. Res. 92, 378-385.
92. Carmeliet, P., Moons, L., Luttun, A., Vincenti, V., Compernolle, V., De Mol, M., Wu, Y., Bono, F., Devy, L., Beck, H., Scholz, D., Acker, T., DiPalma, T., Dewerchin, M., Noel, A., Stalmans, I., Barra, A., Blacher, S., Vandendriessche, T., Ponten, A., Eriksson, U., Plate, K. H., Foidart, J. M., Schaper, W., Charnock-Jones, D. S., Hicklin, D. J., Herbert, J. M., Collen, D., Persico, M. G. (2001) Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditions. Nat. Med. 7, 575-583.
93. Babiak, A., Schumm, A. M., Wangler, C., Loukas, M., Wu, J., Dombrowski, S., Matuschek, C., Kotzerke, J., Dehio, C., Waltenberger, J. (2004) Coordinated activation of VEGFR-1 and VEGFR-2 is a potent arteriogenic stimulus leading to enhancement of regional perfusion. Cardiovasc. Res. 61, 789-795.
94. Deindl, E., Hoefer, I. E., Fernandez, B., Barancik, M., Heil, M., Strniskova, M., Schaper, W. (2003) Involvement of the fibroblast growth factor system in adaptive and chemokine-induced arteriogenesis. Circ. Res. 92, 561-568.
95. Yang, H. T., Deschenes, M. R., Ogilvie, R. W., Terjung, R. L. (1996) Basic fibroblast growth factor increases collateral blood flow in rats with femoral arterial ligation. Circ. Res. 79, 62-69.
96. Horvath, K. A., Doukas, J., Lu, C. Y., Belkind, N., Greene, R., Pierce, G. F., Fullerton, D. A. (2002) Myocardial functional recovery after fibroblast growth factor 2 gene therapy as assessed by echocardiography and magnetic resonance imaging. Ann. Thorac. Surg. 74, 481-486.
97. Caron, A., Michelet, S., Caron, A., Sordello, S., Ivanov, M. A., Delaere, P., Branellec, D., Schwartz, B., Emmanuel, F. (2004) Human FGF-1 gene transfer promotes the formation of collateral vessels and arterioles in ischemic muscles of hypercholesterolemic hamsters. J. Gene Med. 6, 1033-1045.
98. Hershey, J. C., Corcoran, H. A., Baskin, E. P., Gilberto, D. B., Mao, X., Thomas, K. A., Cook, J. J. (2003) Enhanced hindlimb collateralization induced by acidic fibroblast growth factor is dependent upon femoral artery extraction. Cardiovasc. Res. 59, 997-1005.
99. Laham, R. J., Chronos, N. A., Pike, M., Leimbach, M. E., Udelson, J. E., Pearlman, J. D., Pettigrew, R. I., Whitehouse, M. J., Yoshizawa, C., Simons, M. (2000) Intracoronary basic fibroblast growth factor (FGF-2) in patients with severe ischemic heart disease: results of a phase I openlabel dose escalation study. J. Am. Coll. Cardiol. 36, 2132-2139.
100. Wunsch, M., Sharma, H. S., Markert, T., Bernotat-Danielowski, S., Schott, R. J., Kremer, P., Bleese, N., Schaper, W. (1991) In situ localization of transforming growth factor β 1 in porcine heart: enhanced expression after chronic coronary artery constriction. J. Mol. Cell. Cardiol. 23, 1051-1062.
101. Conway, E. M., Collen, D., Carmeliet, P. (2001) Molecular mechanisms of blood vessel growth. Cardiovasc. Res. 49, 507-521.
102. van Royen, N., Hoefer, I., Buschmann, I., Heil, M., Kostin, S., Deindl, E., Vogel, S., Korff, T., Augustin, H., Bode, C., Piek, J. J., Schaper, W. (2002) Exogenous application of transforming growth factor β 1 stimulates arteriogenesis in the peripheral circulation. FASEB J. 16, 432-434.
103. Singh, N. N., Ramji, D. P. (2006) The role of transforming growth factor-β in atherosclerosis. Cytokine Growth Factor Rev. 17, 487-499.
104. Lutgens, E., Gijbels, M., Smook, M., Heeringa, P., Gotwals, P., Koteliansky, V. E., Daemen, M. J. (2002) Transforming growth factor-β mediates balance between inflammation and fibrosis during plaque progression. Arterioscler. Thromb. Vasc. Biol. 22, 975-982.
105. Grundmann, S., van Royen, N., Pasterkamp, G., Gonzalez, N., Tijsma, E. J., Piek, J. J., Hoefer, I. E. (2007) A new intra-arterial delivery platform for pro-arteriogenic compounds to stimulate collateral artery growth via transforming growth factor-β1 release. J. Am. Coll. Cardiol. 50, 351-358.
106. Shireman, P. K. (2007) The chemokine system in arteriogenesis and hind limb ischemia. J. Vasc. Surg. 45 (Suppl. A), A48-A56.
107. Wang, D. L., Wung, B. S., Shyy, Y. J., Lin, C. F., Chao, Y. J., Usami, S., Chien, S. (1995) Mechanical strain induces monocyte chemotactic protein-1 gene expression in endothelial cells. Effects of mechanical strain on monocyte adhesion to endothelial cells. Circ. Res. 77, 294-302.
108. Voskuil, M., Hoefer, I. E., van Royen, N., Hua, J., de Graaf, S., Bode, C., Buschmann, I. R., Piek, J. J. (2004) Abnormal monocyte recruitment and collateral artery formation in monocyte chemoattractant protein-1 deficient mice. Vasc. Med. 9, 287-292.
109. Tang, G., Charo, D. N., Wang, R., Charo, I. F., Messina, L. (2004) CCR2-/- knockout mice revascularize normally in response to severe hindlimb ischemia. J. Vasc. Surg. 40, 786-795.
110. Namiki, M., Kawashima, S., Yamashita, T., Ozaki, M., Hirase, T., Ishida, T., Inoue, N., Hirata, K., Matsukawa, A., Morishita, R., Kaneda, Y., Yokoyama, M. (2002) Local overexpression of monocyte chemoattractant protein-1 at vessel wall induces infiltration of macrophages and formation of atherosclerotic lesion: synergism with hypercholesterolemia. Arterioscler. Thromb. Vasc. Biol. 22, 115-120.
111. van Royen, N., Hoefer, I., Bottinger, M., Hua, J., Grundmann, S., Voskuil, M., Bode, C., Schaper, W., Buschmann, I., Piek, J. J. (2003) Local monocyte chemoattractant protein-1 therapy increases collateral artery formation in apolipoprotein E-deficient mice but induces systemic monocytic CD11b expression, neointimal formation, and plaque progression. Circ. Res. 92, 218-225.
112. van Weel, V., de Vries, M., Voshol, P. J., Verloop, R. E., Eilers, P. H., van Hinsbergh, V. W., van Bockel, J. H., Quax, P. H. (2006) Hypercholesterolemia reduces collateral artery growth more dominantly than hyperglycemia or insulin resistance in mice. Arterioscler. Thromb. Vasc. Biol. 26, 1383-1390.
113. Buschmann, I. R., Hoefer, I. E., van Royen, N., Katzer, E., Braun-Dulleaus, R., Heil, M., Kostin, S., Bode, C., Schaper, W. (2001) GMCSF: a strong arteriogenic factor acting by amplification of monocyte function. Atherosclerosis 159, 343-356.
114. Buschmann, I. R., Busch, H. J., Mies, G., Hossmann, K. A. (2003) Therapeutic induction of arteriogenesis in hypoperfused rat brain via granulocyte-macrophage colony-stimulating factor. Circulation 108, 610-615.
115. Inoue, I., Inaba, T., Motoyoshi, K., Harada, K., Shimano, H., Kawamura, M., Gotoda, T., Oka, T., Shiomi, M., Watanabe, Y., et al. (1992) Macrophage colony stimulating factor prevents the progression of atherosclerosis in Watanabe heritable hyperlipidemic rabbits. Atherosclerosis 93, 245-254.
116. Ishibashi, T., Yokoyama, K., Shindo, J., Hamazaki, Y., Endo, Y., Sato, T., Takahashi, S., Kawarabayasi, Y., Shiomi, M., Yamamoto, T., et al. (1994) Potent cholesterol-lowering effect by human granulocyte-macrophage colony-stimulating factor in rabbits. Possible implications of enhancement of macrophage functions and an increase in mRNA for VLDL receptor. Arterioscler. Thromb. 14, 1534-1541.
117. Zbinden, S., Zbinden, R., Meier, P., Windecker, S., Seiler, C. (2005) Safety and efficacy of subcutaneous-only granulocyte-macrophage colony-stimulating factor for collateral growth promotion in patients with coronary artery disease. J. Am. Coll. Cardiol. 46, 1636-1642.
118. Iwanaga, K., Takano, H., Ohtsuka, M., Hasegawa, H., Zou, Y., Qin, Y., Odaka, K., Hiroshima, K., Tadokoro, H., Komuro, I. (2004) Effects of G-CSF on cardiac remodeling after acute myocardial infarction in swine. Biochem. Biophys. Res. Commun. 325, 1353-1359.
119. Orlic, D., Kajstura, J., Chimenti, S., Limana, F., Jakoniuk, I., Quaini, F., Nadal-Ginard, B., Bodine, D. M., Leri, A., Anversa, P. (2001) Mobilized bone marrow cells repair the infarcted heart, improving function and survival. Proc. Natl. Acad. Sci. USA 98, 10344-10349.
120. Kocher, A. A., Schuster, M. D., Szabolcs, M. J., Takuma, S., Burkhoff, D., Wang, J., Homma, S., Edwards, N. M., Itescu, S. (2001) Neovascularization of ischemic myocardium by human bone-marrow-derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function. Nat. Med. 7, 430-436.
121. Deindl, E., Zaruba, M. M., Brunner, S., Huber, B., Mehl, U., Assmann, G., Hoefer, I. E., Mueller-Hoecker, J., Franz, W. M. (2006) G-CSF administration after myocardial infarction in mice attenuates late ischemic cardiomyopathy by enhanced arteriogenesis. FASEB J. 20, 956-958.
122. Hill, J. M., Syed, M. A., Arai, A. E., Powell, T. M., Paul, J. D., Zalos, G., Read, E. J., Khuu, H. M., Leitman, S. F., Horne, M., Csako, G., Dunbar, C. E., Waclawiw, M. A., Cannon, R. O. (2005) Outcomes and risks of granulocyte colony-stimulating factor in patients with coronary artery disease. J. Am. Coll. Cardiol. 46, 1643-1648.
123. Schachinger, V., Erbs, S., Elsasser, A., Haberbosch, W., Hambrecht, R., Holschermann, H., Yu, J., Corti, R., Mathey, D. G., Hamm, C. W., Suselbeck, T., Werner, H., Haase, J., Neuzner, J., Germing, A., Mark, B., Assmus, B., Tonn, T., Dimmeler, S., Zeiher, A. M. (2006) Improved clinical outcome after intracoronary administration of bone-marrow-derived progenitor cells in acute myocardial infarction: final 1-year results of the REPAIR-AMI trial. Eur. Heart J. 27, 2775-2783.
124. Abdel-Latif, A., Bolli, R., Tleyjeh, I. M., Montori, V. M., Perin, E. C., Hornung, C. A., Zuba-Surma, E. K., Al-Mallah, M., Dawn, B. (2007) Adult bone marrow-derived cells for cardiac repair: a systematic review and meta-analysis. Arch. Intern. Med. 167, 989-997.
125. Lipinski, M. J., Biondi-Zoccai, G. G., Abbate, A., Khianey, R., Sheiban, I., Bartunek, J., Vanderheyden, M., Kim, H. S., Kang, H. J., Strauer, B. E., Vetrovec, G. W. (2007) Impact of intracoronary cell therapy on left ventricular function in the setting of acute myocardial infarction: a collaborative systematic review and meta-analysis of controlled clinical trials. J. Am. Coll. Cardiol. 50, 1761-1767.
126. Van Tongeren, R. B., Hamming, J. F., Fibbe, W. E., Van Weel, V., Frerichs, S. J., Stiggelbout, A. M., Van Bockel, J. H., Lindeman, J. H. (2008) Intramuscular or combined intramuscular/intra-arterial administration of bone marrow mononuclear cells: a clinical trial in patients with advanced limb ischemia. J. Cardiovasc. Surg. (Torino) 49, 51-58.
127. Sprengers, R. W., Lips, D. J., Moll, F. L., Verhaar, M. C. (2008) Progenitor cell therapy in patients with critical limb ischemia without surgical options. Ann. Surg. 247, 411-420.
128. Herold, J., Pipp, F., Fernandez, B., Xing, Z., Heil, M., Tillmanns, H., Braun-Dullaeus, R. C. (2004) Transplantation of monocytes: a novel strategy for in vivo augmentation of collateral vessel growth. Hum. Gene Ther. 15, 1-12.
129. Andreesen, R., Scheibenbogen, C., Brugger, W., Krause, S., Meerpohl, H. G., Leser, H. G., Engler, H., Lohr, G. W. (1990) Adoptive transfer of tumor cytotoxic macrophages generated in vitro from circulating blood monocytes: a new approach to cancer immunotherapy. Cancer Res. 50, 7450-7456.
130. Abaci, A., Oguzhan, A., Kahraman, S., Eryol, N. K., Unal, S., Arinc, H., Ergin, A. (1999) Effect of diabetes mellitus on formation of coronary collateral vessels. Circulation 99, 2239-2242.
131. Waltenberger, J. (2001) Impaired collateral vessel development in diabetes: potential cellular mechanisms and therapeutic implications. Cardiovasc. Res. 49, 554-560.
132. Czepluch, F. S., Bergler, A., Waltenberger, J. (2007) Hypercholesterolemia impairs monocyte function in CAD patients. J. Intern. Med. 261, 201-204.
133. Tirziu, D., Moodie, K. L., Zhuang, Z. W., Singer, K., Helisch, A., Dunn, J. F., Li, W., Singh, J., Simons, M. (2005) Delayed arteriogenesis in hypercholesterolemic mice. Circulation 112, 2501-2509.
134. Kornowski, R. (2003) Collateral formation and clinical variables in obstructive coronary artery disease: the influence of hypercholesterolemia and diabetes mellitus. Coron. Artery Dis. 14, 61-64.
135. Hochberg, I., Roguin, A., Nikolsky, E., Chanderashekhar, P. V., Cohen, S., Levy, A. P. (2002) Haptoglobin phenotype and coronary artery collaterals in diabetic patients. Atherosclerosis 161, 441-446.
136. Gulec, S., Karabulut, H., Ozdemir, A. O., Ozdol, C., Turhan, S., Altin, T., Tutar, E., Genc, Y., Erol, C. (2008) Glu298Asp polymorphism of the eNOS gene is associated with coronary collateral development. Atherosclerosis 198, 354-359.
137. Chittenden, T. W., Sherman, J. A., Xiong, F., Hall, A. E., Lanahan, A. A., Taylor, J. M., Duan, H., Pearlman, J. D., Moore, J. H., Schwartz, S. M., Simons, M. (2006) Transcriptional profiling in coronary artery disease: indications for novel markers of coronary collateralization. Circulation 114, 1811-1820.
138. Schirmer, S. H., Fledderus, J. O., Bot, P., Moerland, P. D., Hoefer, I., Baan, J., Henriques, J. P. S., van der Schaaf, R. J., Vis, M. M., Horrevoets, A. J., Piek, J. J., Van Royen, N. (2008) Interferon-β signaling is enhanced in patients with insufficient coronary collateral artery development and inhibits arteriogenesis in mice. Circ. Res. 102, 1286-1294.